Veterinary Medicines

TETANUSAN 50 % NOVO, injekcinis tirpalas

Authorised
  • Sodium glycerophosphate pentahydrate
  • Magnesium chloride hexahydrate
  • Calcium gluconate monohydrate
Download as PDF

Product identification

Medicine name:
TETANUSAN 50 % NOVO, injekcinis tirpalas
Active substance:
  • Sodium glycerophosphate pentahydrate
  • Magnesium chloride hexahydrate
  • Calcium gluconate monohydrate
Target species:
  • Cattle
  • Horse
  • Pig
  • Cattle (calf)
  • Horse (foal)
Route of administration:
  • Intravenous use
  • Subcutaneous use

Product details

Active substance and strength:
  • Sodium glycerophosphate pentahydrate
    20.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Magnesium chloride hexahydrate
    125.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Calcium gluconate monohydrate
    440.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intravenous use
    • Cattle
      • Meat and offal
        0
        day
      • Milk
        0
        day
    • Horse
      • Meat and offal
        0
        day
      • Milk
        0
        day
    • Pig
      • Meat and offal
        0
        day
    • Cattle (calf)
    • Horse (foal)
  • Subcutaneous use
    • Cattle
      • Meat and offal
        0
        day
      • Milk
        0
        day
    • Horse
      • Meat and offal
        0
        day
      • Milk
        0
        day
    • Pig
      • Meat and offal
        0
        day
    • Cattle (calf)
    • Horse (foal)
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA12CX99
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Lithuania
Available in:
  • Lithuania
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Well-established use application (Article 13a of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Kon-Pharma GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bela-Pharm GmbH & Co. KG
Responsible authority:
  • State Food And Veterinary Service
Authorisation number:
  • LT/2/07/1769/001
Date of authorisation status change:

Documents

RV1769.pdf

Lithuanian (PDF)
Published on: 1/03/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."